Satsuma Pharmaceuticals : Termination of Material Agreement - Form 8-K

8-K



UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549






... | June 8, 2023

Related Keywords

Japan ,Washington ,United States ,Delaware ,State Of Delaware ,American ,Nippon ,Japanese ,Thomasb King ,Tom Soloway ,Shinji Nitanda ,Mutya Harsch ,Shunji Haruta ,Michael Riebe ,Rajeev Shah ,John Kollins ,Ken Takanashi ,Heath Lukatch ,Tom Oneil ,Shuichi Kanazashi ,Akihisa Mori ,Ryoichi Nagata ,Merger The Surviving Corporation ,Certificate Of Incorporation The Company ,Virtu Americas ,American Stock Transfer Trust Company ,Exchange Commission On ,Securities Exchange ,Company Current Report On Form ,Corporation Law Of The State Delaware ,Company The Merger ,Satsuma Pharmaceuticals Inc ,Nasdaq ,Shin Nippon Biomedical Laboratories Ltd ,Merger Sub Inc ,Bylaws Of The Company ,Company On ,Securities Exchange Act ,Zip Code ,Securities Act ,Exchange Act ,Current Report ,Satsuma Pharmaceuticals ,Shin Nippon Biomedical Laboratories ,Merger Sub ,Material Definitive Agreement ,Incentive Plan ,Award Plan ,Stock Purchase ,At The Marketsales Agreement ,Sales Agreement ,Exchange Commission ,Merger Agreement ,Stock Transfer ,Trust Company ,Guaranteed Delivery ,General Corporation Law ,American Stock Transfer ,Offer Price ,Effective Time ,Company Option ,Continued Listing Rule ,Nasdaq Stock Market ,Security Holders ,Introductory Note ,Certain Officers ,Compensatory Arrangements ,Elisabeth Sandoval Little ,Chief Executive Officer ,Tomo Neil ,Chief Financial Officer ,Fiscal Year ,Restated Certificate ,Restated Bylaws ,Fifth Amended ,Page Interactive Data File ,Nc Stock Exchange ,News ,Information ,Press Release ,United ,Securities ,End ,Xchange Stsa Us80405p1075 ,